loading page

Bibliometric Analysis to Explore Trends of the 100 Most Cited Articles in Population Pharmacokinetic and/or Pharmacodynamic Modelling
  • Nur Mardhiya Darnalis,
  • Hadzliana Zainal,
  • Eva Germovsek
Nur Mardhiya Darnalis
Universiti Sains Malaysia
Author Profile
Hadzliana Zainal
Universiti Sains Malaysia

Corresponding Author:[email protected]

Author Profile
Eva Germovsek
Boehringer Ingelheim Pharma GmbH und Co KG
Author Profile

Abstract

Abstract Aims This bibliometric study aim to analyse the top 100 most cited articles since inception (1964-2021) and in the recent years (2015-2021) to explore the trends of most cited papers using data from the Scopus database. Methods We bibliometrically analysed the most cited articles (n=100) extracted from the Scopus online database from inception (1964-2021) and again in the recent years (2015-2021) using VOSviewer v1.6.15 and Publish or Perish v8 software. Information such as ATC/drug class, model type, software used, studied population, authors’ institutions, journals, collaborations between countries, and funding sources was extracted and compared. Results Majority of the studies (65%) described in the 100 most cited articles were population PK modelling studies, with the proportion of the population PKPD modelling studies increasing over time (from 30 to 43%). A large percentage of the impactful articles (43%) were published by top five journals, analysed adult data (84%) and used NONMEM® (80%), which has not changed much over time. Most of the impactful articles studied chemotherapeutic and immunomodulating (33%), anti-infective (29%), and central nervous system (22%) ATC class of drugs, with articles analysing immunosuppressant drug class increasing the most over time (from 10% to 18%). Conclusion We used a bibliometric approach and investigated research trends in top 100 most cited articles involving PK(/PD) modelling. Apart from the changes mentioned above most other metrics that we compared remained relatively unchanged over time